Publication: Methylchloroisothiazolinone and/or methylisothiazolinone in cosmetic products—A market survey
| dc.contributor.author | Thanisorn Sukakul | en_US |
| dc.contributor.author | Dollaporn Kanchanapenkul | en_US |
| dc.contributor.author | Monthathip Bunyavaree | en_US |
| dc.contributor.author | Pichaya Limphoka | en_US |
| dc.contributor.author | Titinun Kumpangsin | en_US |
| dc.contributor.author | Waranya Boonchai | en_US |
| dc.contributor.other | Faculty of Medicine, Siriraj Hospital, Mahidol University | en_US |
| dc.date.accessioned | 2020-01-27T10:08:02Z | |
| dc.date.available | 2020-01-27T10:08:02Z | |
| dc.date.issued | 2019-02-01 | en_US |
| dc.description.abstract | © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: There was a global epidemic of methylchloroisothiazolinone (MCI) and/or methylisothiazolinone (MI) contact allergy from 2009 to 2015. In response, the Thai Ministry of Public Health regulated the use of MCI/MI in cosmetics. Objective: To survey the presence of MCI/MI and MI alone, as labelled on cosmetics sold on the Thai market, before and after the ministerial directive. Methods: The presence of MCI and/or MI in leave-on and rinse-off cosmetics sold on the market, based on the labelling of ingredients in 3445 products, was analysed. Results: Before the implementation date, most leave-on products contained MCI/MI. After the regulations came into force, the only leave-on cosmetic subcategories that complied with the law were facial skin-care, sunscreen and make-up products. MCI/MI and MI alone were found on the labels of both leave-on and rinse-off products, the presence of each varying between product subcategories. Conclusions: Despite the ministerial regulations restricting their use, MCI and/or MI are still found in cosmetics sold on the Thai market. Dermatologists should be aware of this situation, and counsel patients to avoid products containing MCI and/or MI. | en_US |
| dc.identifier.citation | Contact Dermatitis. Vol.80, No.2 (2019), 110-113 | en_US |
| dc.identifier.doi | 10.1111/cod.13151 | en_US |
| dc.identifier.issn | 16000536 | en_US |
| dc.identifier.issn | 01051873 | en_US |
| dc.identifier.other | 2-s2.0-85056611052 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/51903 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056611052&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Methylchloroisothiazolinone and/or methylisothiazolinone in cosmetic products—A market survey | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056611052&origin=inward | en_US |
